This article is a correction to:
Biomolecules as Model Indicators of In Vitro and In Vivo Cold Plasma Safety
Caitlin Heslin1
Daniela Boehm1*
Brendan F. Gilmore2
Julianne Megaw2
Theresa A. Freeman3
Noreen J. Hickok3P. J. Cullen1,4
Paula Bourke1,5,6*- 1School of Food Science and Environmental Health, Technological University Dublin, Dublin, Ireland
- 2School of Pharmacy, Queens University Belfast, Belfast, United Kingdom
- 3Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Jefferson University, Philadelphia, PA, United States
- 4School of Chemical and Biomolecular Engineering, University of Sydney, Sydney, NSW, Australia
- 5School of Biological Sciences, Queens University Belfast, Belfast, United Kingdom
- 6Plasma Research Group, School of Biosystems and Food Engineering, University College Dublin, Dublin, Ireland
A corrigendum on
Biomolecules as Model Indicators of In Vitro and In Vivo Cold Plasma Safety
by Heslin C, Boehm D, Gilmore BF, Megaw J, Freeman TA, Hickok NJ, et al. Front Phys (2021) 8:613046. doi:fphy.2020.613046
In the original article, the reference for [16] was incorrectly written as “Khlyustova A, Jarzina F, Brinckmann S. Important parameters in plasma jets for the production of RONS in liquids for plasma medicine: a brief review. Front Chem Sci Eng (2019) 13:238–52. doi: 10.1007/s11705-019-1801-8.”
This should be “Khlyustova A, Labay C, Machala Z, Ginebra MP, Canal C. Important parameters in plasma jets for the production of RONS in liquids for plasma medicine: a brief review. Front Chem Sci Eng (2019) 13:238–52. doi: 10.1007/s11705-019-1801-8.”
Further, the reference for [17] was incorrectly written as “Labay C, Shimizu T, Thomas HM, Morfill GE. Enhanced generation of reactive species by cold plasma in gelatin solutions for selective cancer cell death. ACS Appl Mater Interfaces (2020) 12(42):47256–69. doi: 10.1021/acsami.0c12930.”
This should be “Labay, C, Roldán, M, Tampieri, F, Stancampiano, A, Escot Bocanegra, P, Ginebra, MP, Canal, C. Enhanced generation of reactive species by cold plasma in gelatin solutions for selective cancer cell death. ACS Appl Mater Interfaces (2020) 12(42):47256–69. doi: 10.1021/acsami.0c12930.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
References
16. Khlyustova A, Labay C, Machala Z, Ginebra M-P, Canal C. Important parameters in plasma jets for the production of RONS in liquids for plasma medicine: a brief review. Front Chem Sci Eng (2019) 13:238–52. doi:10.1007/s11705-019-1801-8
Keywords: cold atmospheric plasma, cytotoxicity, mutagenicity, safety, in vivo toxicity
Citation: Heslin C, Boehm D, Gilmore BF, Megaw J, Freeman TA, Hickok NJ, Cullen PJ and Bourke P (2021) Corrigendum: Biomolecules as Model Indicators of In Vitro and In Vivo Cold Plasma Safety. Front. Phys. 9:664663. doi: 10.3389/fphy.2021.664663
Received: 05 February 2021; Accepted: 08 February 2021;
Published: 14 April 2021.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2021 Heslin, Boehm, Gilmore, Megaw, Freeman, Hickok, Cullen and Bourke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paula Bourke, paula.bourke@ucd.ie; Daniela Boehm, daniela.boehm@tudublin.ie